Background: At the end of 2019, a novel coronavirus outbreak emerged in Wuhan, China,
and its causative organism has been subsequently designated the 2019 novel coronavirus …

Background: At the end of 2019, a novel coronavirus outbreak causative organism has been
subsequently designated the 2019 novel coronavirus (2019-nCoV). The effectiveness of …

Background Glucocorticoids are widely used in the treatment of various pulmonary
inflammatory diseases, but they are also often accompanied by significant adverse …

The aim of the present study was to identify the clinical efficacy of glucocorticoid therapy on
the treatment of patients with Coronavirus Disease 2019 (COVID-19) pneumonia. Clinical …

The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-
19. A systematic search of the literature across nine databases was conducted from …

Objectives An outbreak of novel coronavirus in 2019 threatens the health of people, and
there is no proven pharmacological treatment. Although corticosteroids were widely used …

BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Background Corticosteroids are commonly used as adjuvant therapy for acute respiratory
distress syndrome by many clinicians because of their perceived anti-inflammatory effects …

Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …

To evaluate the efficacy of corticosteroids on coronavirus disease 2019 (COVID‐19) patients
with different levels of disease severity. In our multicenter study, 543 patients with confirmed …